The nCounter analysis system at Washington University will be utilized first for a large-scale diabetes study to validate the expression of over 50 genes across 15 tissues in over 900 samples.
The company said that the nCounter analysis system uses a novel digital technology that enables direct multiplexed measurement of gene expression and offers high levels of sensitivity and precision, including detection of fractional fold change differences, a feature unique to this platform.